Navigation Links
Bayer HealthCare Awards Veterinary Students $72,500 in Scholarship Funds for Communications Excellence
Date:11/20/2013

SHAWNEE, Kan., Nov. 20, 2013 /PRNewswire/ -- Bayer HealthCare LLC, Animal Health division announces the launch of the 2014 Bayer Excellence in Communication Award. Rolled out to veterinary students at 28 schools across North America, the award is designed to encourage development of effective communication skills among future veterinarians. The program offers eligible students the chance to compete for one $2,500 scholarship at each participating school by demonstrating strong communication skills with a client in a clinical setting. To compete for the national award, school winners must submit a video of their client interview. The national winner will receive an additional $2,500 scholarship. Scholarships totaling $72,500 will be awarded by Bayer.

The Bayer Excellence in Communication Award was created in response to findings from the Bayer Veterinary Care Usage Study that revealed a communication gap between veterinarians and pet owners, especially as it relates to the value placed on regular veterinary care. Effective communication with pet owners is imperative to becoming a successful veterinarian.[1]

"The purpose of the Bayer Excellence in Communication Award is to help develop strong communications skills among veterinarians that will in turn, result in healthier pets," said Cristiano von Simson, DVM, MBA, director of Veterinary Services, Bayer HealthCare Animal Health. "The overwhelmingly positive response to the award last year, our inaugural year that involved seven veterinary schools, led to our expanding to 21 additional schools. We are confident that student submissions will help encourage other veterinary students to sharpen their veterinary communications skills."

Shaping communications skills from the beginning
In 2001, Bayer HealthCare Animal Health partnered with the Institute for Healthcare Communication to develop the Bayer Communication Project. This collaborative partnership led to the development of a communication skills training module offered to colleges of veterinary medicine. Selected faculty from all U.S. veterinary colleges, trained via the Bayer Communication Project "Train the Trainer" development program, have, in turn, incorporated this training into their curriculum.

Participation in the 2014 Bayer Excellence in Communication Award is open to juniors and seniors enrolled at the participating veterinary colleges. Judging and selection of school-level winners is determined by faculty at each respective college. The national winner will be selected by an independent panel of Bayer Communication Project-trained faculty using a standardized score sheet to evaluate each submission. School-level winners will be selected by March 1, 2014, while the national winner will be chosen by May 1, 2014.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of €18.6 million (2012), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,300 employees (Dec 31, 2012) and is represented in more than 100 countries. More information at www.healthcare.bayer.com.

Contact:
Staci Gouveia, Tel. 913.268.2577
Email: staci.gouveia@bayer.com

Lauren Dorsch, Tel. 913.268.2747
Email: lauren.dorsch@bayer.com

Find more information about Bayer HealthCare Animal Health at www.animalhealth.bayerhealthcare.com
Follow us on Twitter: @Bayer4animalsUS
Follow us on Facebook: http://www.facebook.com/healthcare.bayer 

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

©Bayer and the Bayer Cross are registered trademarks of Bayer.

[1] International Veterinary Communication Institute, "What is the International Veterinary Communication Institute (IVCI)?" http://www.iccvm.com/index.html. Accessed September 4, 2013.


'/>"/>
SOURCE Bayer HealthCare LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
2. Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy
3. Among the Novel Oral Anticoagulants, Bayer/Janssens Xarelto is Positioned To Be the Sales-Leading Therapy for Venous Thromboembolism (VTE)
4. FDA Advisory Committee Unanimously Recommends Approval Of Bayers Riociguat In Two Pulmonary Hypertension Indications
5. Statement: Bayer Mourns Passing of Senator Frank Lautenberg
6. Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
7. Bayer Employee Named Rising Star by Healthcare Businesswomens Association
8. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
9. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
10. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
11. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  New research provides evidence ... advanced Parkinson,s, according to a study released today that will ... Annual Meeting in Boston , April ... to the treatment of Parkinson,s disease, the oral drug levodopa ... life and longevity. But as the disease progresses, the effects ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® ... to announce the integration of IBM ® Watson ... to deliver targeted communications for a personalized experience. Through ... actions on their health in real time. The enhanced ... matter most to members, wherever they are in their ...
(Date:4/18/2017)... -- Research and Markets has announced the addition ... Equipment and Radiopharmaceuticals Market, Forecast to 2023" report to ... This ... well as growth in the number of unit shipments over ... participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):